Who invested in Converge Bio?
Converge Bio's investors include TLV Partners, Bessemer Venture Partners, Saras Capital and Vintage Investment Partners. Bessemer Venture Partners led its latest round.

United States · Series A startup
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 10 months ago
Follow Converge Bio and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$31Mraised across 2 rounds since 2024, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by TechCrunchSEC filing: $25M sold
Converge Bio filed one raise, $25M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Converge Bio's own website: 3 founders, 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Converge Bio's investors include TLV Partners, Bessemer Venture Partners, Saras Capital and Vintage Investment Partners. Bessemer Venture Partners led its latest round.
Converge Bio has raised $31M across 2 rounds since 2024.
Converge Bio's most recent round was a Series A of $25M in Jan 2026, led by Bessemer Venture Partners.
Its most recent round, $25M in Jan 2026, is also its largest on record.
Converge Bio's first round on record, in Nov 2024, was backed by TLV Partners.
Converge Bio's latest named round is a Series A, in Jan 2026.
Converge Bio is based in the United States.
TLV Partners led the Seed in 2024; Bessemer Venture Partners led the Series A in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.